of which were confirmed by 'C NMR spectra (Table 3) .
19, which was obtained as main product by controling the reaction conditions, was treated with mesyl chloride in pyridine to give 4'-epi-chloro derivative (22). 4'-O-Mesylation followed by SN_ substitution by chloride anion formed from mesyl chloride seems to occur in the reaction.
Desilylation of 22 by tetrabutylammonium fluoride gave the free 4'-epi-chloride (23), which under- Antibacterial Activity
The derivatives of neospiramycin I were evaluated by antibacterial activity (MIC), affinity to ribosomes (ID,,) and retention time (RT) in HPLC, as shown in Table 6 . Since it is known that the binding of a macrolide to the 50S subunit of bacterial ribosome causes inhibition of protein synthesis, the ID;,, Recently, it has been reported that 10-(Z)-derivatives of carbomycin, deltamycin and 4"-phenylacetyideltamycin show higher antimicrobial activity,13) which is interesting in the similarity to 12-(Z)-derivatives of neospiramycin I. Experimental NMR spectra were measured on a Jeol FX-100 spectrometer in CDCI, Solution (Tables 1 -3) . Mass spectra were obtained on a Jeol D-100 and DX-300 spectrometer at 20 eV (Table 5) . Optical rotations were measured with a Jasco DIP-181 polarimeter.
Thin-layer chromatography (TLC) was performed on pre-coated plates, Merck Kiesel gel 60 F,;, with CHCI. -MeOH -cone NH,OH, 10: 1: 0.01 without cited. Silica gel column chromatography was performed with Merck Kiesel gel 60.
Minimum Inhibitory Concentration MIC values against various bacteria were determined by the agar dilution method using heart infusion agar (pH 7.0).
ID;,, for the Binding to Ribosomes
The 50% inhibition dose (ID;,,) of the derivatives for [10,11,12,13-` H]tetrahvdroleucomycin A binding to Escherichia coli ribosomes were determined as described previously."
Retention Time (RT) in HPLC HPLC was performed on a reverse phase silica gel column (Merck LiChrosorb RP-8, 4 min x 250 mm) with CH3CN -0.2 M NaH_PO" 1: 2 as a solvent system.''-!, RT was recorded at 1 ml/minute of flow rate with a UV monitor (231 nm).
2'-O-Acetyl-4'-O-benzylsulfonyl-3-O-tetrahydrofuranylneospiramycin 1 (3)
To a solution of 2'-O-acetyl-3-O-tetrahydrofuranylneospiramycin 1', (2) (1.00 g) in pyridine (20 ml), benzylsulfonyl chloride (517 mg) was added and stood for 1.5 hours at room temp. The reaction mixture was poured into H,O (100 ml) and extracted with CHCI; (100 ml 3). The CHCl3 solution was dried over anhydrous sodium sulfate and evaporated in racuo. The residual solid was dissolved in toluene -Me.,CO, 4: 1 (3 ml) and the insoluble solid of 3 (681 mg) was filtered.
The filtrate was 
2'-O-Acetyl-4'-epi-chloro-4'-deoxy-3-O-tetrahydrofuranylneospiramycin I (4)
To a solution of 3 (600 mg) in CHCI;, -Me.CO, 1: 3 (16 ml), lithium chloride (264 mg) and triethylamine (0.07 ml) were added and heated to refiux for 5 hours.
The reaction mixture was diluted with CHCL, (60 ml) and washed with H ,O (100 ml). The CHCI, solution was dried over anhydrous sodium sulfate and evaporated to give a powder, which was chromatographed on a silica gel column with C,,H, -Me: CO, 4: 1, to give a colorless powder, 278 mg (53.9%). TLC Rf 0.50; [n]-, -34.2' (c 1.0, CHCI ).
2'-O-Acetyl-4'-O-mesyl-3-O-tetrahydrofuranylneospiramycin I (5)
To a solution of 2 (760 mg) in pyridine (24 ml), mesyl chloride (0.41 nil) was added and stood for 45 minutes at room temp. The reaction mixture was poured into H.O (100 ml) and extracted with CHCI; (100 ml x 3). The CHCI, solution was dried over anhydrous sodium sulfate and evaporated to give a powder, which was chromatographed on a silica gel column with C, H_ -Me_CO, 2: 1, to give a colorless powder, 588 mg (70.3 °;;). TLC Rf 0.71.
2'-O-Acetyl-4'-epi-3-O-tetrahydrofuranylneospiramycin 1 (6) A solution of 5 (580 mg) in 50'%` Me-CO (23 nil) was held for 8 days at room temp. The reaction mixture was poured into a saturated solution of sodium hydrogen carbonate (60 nil) and extracted with CHCI. (60 ml,,/ 3). The CHCI, solution was dried over anhydrous sodium sulfate and evaporated to give a powder, which was chromatographed on a silica gel column with C,;H. To a solution of 4 (169 mg) in toluene (3.4 ml), tributyltin hydride (1.0 ml) and a,a'-azobisisobutyronitrile (11 mg) were added and heated at 80°C for 1 hour under a stream of nitrogen gas. The reaction mixture was diluted with CHC13 (20m]) and washed with H_O. The CHCI; solution was dried over anhydrous sodium sulfate and evaporated, to give an oily residue. The oil was chromatographed on a column of silica gel with C,H,, -Me.,CO, 2: 1, to give 10, 11, 8 and 9 in the order of elution. 
4'-Deoxy-3-O-b-tetrahydrofuranylneospiramycin I (13)
A solution of 9 (40 mg) in MeOH (1.6 ml) was held for 2 days at room temp. The reaction mixture was evaporated, to give a crude powder, 26 mg, TLC Rf 0.19. Further purification failed because of its instability.
12-(Z)-4'-Deoxy-3-O-a-tetrahydrofuranylneospiramycin I (14)
A solution of 10 (30 mg) in MeOH (1. To a solution of a mixture of 12-15 (123 mg, prepared from 4 in a similar way described above without separation of each epimers arising from tetrahydrofuranyl group) in dioxane -HO, 1 : 1 (2.5 ml), pyridiniump-toluenesulfonate (41 mg) was added and heated at 45°C for 40 hours. The reaction mixture was diluted with HO (15 ml) and extracted with CHCI3 (15 ml '< 3). The CHCI; solution was dried over anhydrous sodium sulfate and evaporated to give a powder, which was chromatographed on a silica gel preparative TLC plate with a lower layer of CHCI; -MeOH -1. 2'-O-Acetyl-4'-epi-chloro-4'-deoxy-3-O-mesylneospiramycin I (25) To a solution of 1 (17.0 g) in pyridine (340 ml), mesyl chloride (3.2 ml) was added and held for 1 hour at room temp. The reaction mixture was poured into H,O (1.5 liters) and extracted with CHCI3 (1.5 liters x 3). The CHCI3 solution was dried over anhydrous sodium sulfate and evaporated, to give a powder. To a solution of the powder in CHCI3 -Me.,CO, 1: 1 (360 ml), lithium chloride (9.80 g) and triethylamine (2.3 ml) were added and heated to reflux for 2.5 hours. The reaction mixture was diluted with CHCIa (1.0 liter) and washed with H.,O (1.5 liters). The CHCI3 layer was dried over anhydrous sodium sulfate and evaporated, and the residual powder was chromatographed on a silica gel 24 A solution of 25 (3.00 g) in a saturated solution of sodium carbonate in McOH (60 ml) was stirred for 3 hours at room temp.
The reaction mixture was evaporated and the residue was dissolved in CHCI3 (300 ml) and washed with MO (300 ml). The CHCI3 solution was dried over anhydrous sodium sulfate and evaporated, to give a powder, which was chromatographed on a silica gel column with CHCI3 -MeOH, 45: 1, to give a colorless powder, 2.39 g (90.0%). To a solution of 26 (2.50 g) in toluene (50 ml), tributyltin hydride (17 .7 ml) and a,cr'-azobisisobutyronitrile (177 mg) were added and heated at 80'C for 1 hour under a stream of nitrogen gas . The reaction mixture was diluted with CHCI3 (250 ml) and washed with H,O (250 ml) . The CHC13 solution was dried over anhydrous sodium sulfate, evaporated , and oily residue was chrornatographed on a silica gel column with C;H, -Me.CO, 2: 1, giving 28 and 27 in the order of elution.
27, a colorless powder, 264 mg ( 
